Molecular mechanisms of oxygen-induced lung injury

Chronic Lung Disease in Early Infancy

Volumn , Issue , 1999, Pages 749-778

  Smith, Charles Vincent ^a   Welty, Stephen E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897521165     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (147)

1. Zimmerman JJ. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 1995; 22:429-456.
2. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin North Am 1994; 41:277-315.
3. Northway WH Jr. An introduction to bronchopulmonary dysplasia. Clin Perinatol 1992; 19:489-495.
4. Northway WH Jr. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 1992; 89:969-973.
5. Frank L, Sosenko IRS. Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J Pediatr 1987; 110:9-14.
6. Frank L, Sosenko IRS. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987; 110:106-110.
7. Loeb GA, Skelton DC, Forman HJ. Dependence of mixed disulfide formation in alveolar macrophages upon production of oxidized glutathione: effect of selenium depletion. Biochem Pharmacol 1989; 38:3119-3121.
8. Cantin AM, Begin R. Glutathione and inflammatory disorders of the lung. Lung 1991; 169:123-138.
9. Zimmerman GA, Prescott SM, McIntyre TM. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. J Nutr 1995; 125:1661S-1665S.
10. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Kosick R, Zimmerman JJ. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 1996; 24:29-37.
11. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994; 93: 712-718.
12. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19:371-378.
13. Shi MM, Godleski JJ, Paulauskis JD. Regulation of macrophage inflammatory protein-1a mRNA by oxidative stress. J Biol Chem 1996; 271:5878-5883.
14. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210-215.
15. Elsayed NM. Toxicology of blast overpressure. Toxicology 1997; 121:1-15.
16. Elsayed NM, Gorbunov NV, Kagen VE. A proposed biochemical mechanism involving hemoglobin for blast overpressure-induced injury. Toxicology 1997; 121: 81-90.
17. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am Rev Respir Dis 1997; 155:1187-1205.
18. Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animal of various species. J Appl Physiol 1978; 45:699-704.
19. Yam J, Frank L, Roberts RJ. Oxygen toxicity: comparison of lung biochemical responses in neonatal and adult rats. Pediatr Res 1978; 12:115-119.
20. Frank L, Sosenko IS. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 1991; 29:292-296.
21. Sosenko IR, Frank L. Guinea pig lung development: antioxidant enzymes and premature survival in high O2. Am J Physiol 1987; 252:R693-R698.
22. Sosenko IR, Frank L. Lung development in the fetal guinea pig: surfactant, morphology, and premature viability. Pediatr Res 1987; 21:427-431.
23. De Lemos R, Wolfsdorf J, Nachman R, et al. Lung injury from oxygen in lambs. Anesthesiology 1969; 30:609-618.
24. Crapo JD, Barry BE, Foscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980; 122:123-143.
25. Bressack MA, McMillan DD, Bland RD. Pulmonary oxygen toxicity: increased microvascular permeability to protein in unanesthetised lambs. Lymphology 1979; 12:133-139.
26. Hansen TN, Hazinski TA, Bland RD. Vitamin E does not prevent oxygen-induced lung injury in newborn lambs. Pediatr Res 1982; 16:583-587.
27. Newman JH, Loyd JE, English DK, Ogletree ML, Fulderson WJ, Brigham KL. Effects of 100% oxygen on lung vascular function in awake sheep. J Appl Physiol 1983; 54:1379-1386.
28. Fukushima M, King LS, Kang K, Banerjee M, Newmann JH. Lung mechanics and airway reactivity in sheep during development of oxygen toxicity. J Appl Physiol 1990; 69:1779-1785.
29. Hazinski TA, Kennedy KA, France ML, Hansen TN. Pulmonary O2 toxicity in lambs: physiological and biochemical effects of endotoxin infusion. J Appl Physiol 1988; 65:1579-1585.
30. Smith LJ, Friedman H, Anderson J. Hyperoxic lung injury in mice: effect of neutrophil depletion and food deprivation. J Lab Clin Med 1988; 111:449-458.
31. Smith LJ. Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. J Lab Clin Med 1985; 106:269-278.
32. Berg JT, Allison RC, Taylor AT. Endotoxin extends survival of adult mice in hyper- oxia. Proc Soc Exp Biol Med 1990; 90:167-170.
33. Turrens JF, Freeman BA, Crapo JD. Hyperoxia increases H2O2 release by lung mitochondria and microsomes. Arch Biochem Biophys 1982; 217:411-421.
34. Deneke SM, Gershoff SN, Fanburg BL. Potentiation of oxygen toxicity in rats by dietary protein or amino acid deficiency. J Appl Physiol 1983; 54:147-151.
35. Deneke SM, Lynch BA, Fanburg BL. Effects of low protein diets or feed restriction on rat lung glutathione and oxygen toxicity. J Nutr 1985; 115:726-732.
36. Fanburg BL, Deneke SM. Protein deficiency potentiates oxygen toxicity. Exp Lung Res 1988; 14:911-919.
37. Stenzel JD, Welty SE, Benzick AE, Smith EO, Smith CV, Hansen TN. Hyperoxic lung injury in Fischer-344 and Sprague-Dawley rats in vivo. Free Radic Biol Med 1993; 14:531-539.
38. Awasthi S, Gyurasics A, Knight SA, Welty SE, Smith CV. Protein oxidation biomarkers in hyperoxic lung injury in rats: effects of U-74389. Toxicol Lett 1998; 95:47-61.
39. Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH. Compartmentation of glutathione. Implications for the study of toxicity and disease. Toxicol Appl Pharmacol 1996; 140:1-12.
40. Levine RL. Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. J Biol Chem 1983; 258:11823-11827.
41. Stadtman ER. Protein oxidation and aging. Science 1992; 257:1220-1224.
42. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233:346-357.
43. Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay. Free Radic Biol Med 1994; 17:429-437.
44. Gladstone IM, Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics 1994; 93:764-768.
45. Knight SA, Smith CV, Welty SE. Iron and oxidized P-casein in the lavages of hyperoxic Fischer-344 rats. Life Sci 1997; 62:165-176.
46. Wearden ME, Dzdic N, Rogers LK, Smith CV. Oxidation of lung proteins in rats exposed to inhaled nitric oxide and hyperoxia [abstr]. Pediatr Res 1998; 43:202A.
47. Wearden ME, Hegemier SE, Dzdic N, et al. Protein oxidation and nitrotyrosine formation in tracheal aspirate fluids of mechanically ventilated neonates exposed to hyperoxia and/or inhaled nitric oxide [abstr]. Pediatr Res 1998; 43:203A.
48. Yang C-Y, Gu Z-W, Yang H-X, Gotto AM Jr, Smith CV. Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCl in vitro. Free Radic Biol Med 1997; 23:82-89.
49. Smith CV, Rogers LK, Garcia-Prats AJ, Gu ZW, Yang C-Y. Oxidation of cysteine residues in proteins by myeloperoxidase (MPO) or HOCl in vitro produces sulfenyl or sulfonyl chloride intermediates [abstr]. Pediatr Res 1998; 43:196A.
50. Freeman BA, Topolosky MK, Crapo JD. Hyperoxia increases oxygen radical production in rat lung homogenates. Arch Biochem Biophys 1982; 216:477-484.
51. Kiezka H, Kappus H. Oxygen dependence of CCl4-induced lipid peroxidation in vitro and in vivo. Toxicol Lett 1980; 5:191-196.
52. Ortiz de Montellano PR. Catalytic sites of hemoprotein peroxidases. Annu Rev Pharmacol Toxicol 1992; 32:89-107.
53. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991; 11:463-494.
54. Frank L. Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin Perinatol 1992; 19:541-562.
55. Freeman BA, Young SL, Crapo JD. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 1983; 258: 12534-12542.
56. Oury TD, Chang L-Y, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 70:889-898.
57. Hazinski TA, France M, Kennedy KA, Hansen TN. Cimetidine reduces hyperoxic lung injury in lambs. J Appl Physiol 1989; 67:2586-2592.
58. Gonder JC, Proctor RA, Will JA. Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci USA 1985; 82:6315-6319.
59. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-821.
60. Harlan JM, Schwartz BR, Reidy MA, Schwartz SM, Ochs HD, Harker LA. Activated neutrophils disrupt endothelial monolayer integrity by an oxygen radical- independent mechanism. Lab Invest 1985; 52:141-150.
61. Pontremoli S, Melloni E, Michetti M, et al. Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase. Proc Natl Acad Sci USA 1986; 83:1685-1689.
62. Tsaka T, Herkner KR. Polymorphonuclear elastase in neonatal sepsis. Clin Chim Acta 1990; 193:103-112.
63. Simchowitz L, Spilberg I. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: evidence for the role of sodium. J Immunol 1979; 123:2428-2435.
64. Thomas EL, Learn DB, Jefferson MM, Weatherred W. Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils. J Biol Chem 1988; 263:2178-2186.
65. Carden DL, Smith JK, Korthius RJ. Oxidant-mediated, CD 18-dependent microvas- cular dysfunction induced by complement-activated granulocytes. Am J Physiol 1991; 260:H1144--H1152.
66. Nathan CF. Neutrophil activation on biological surfaces. J Clin Invest 1987; 80: 1550-1560.
67. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony- stimulating factors CSF-GM and CSF-G. Blood 1989; 73:301-306.
68. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 inte- grins. J Cell Biol 1989; 109:1341-1349.
69. Shappell SB, Toman C, Anderson DC, Taylor AA, Entman ML, Smith CW. Mac- 1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 1990; 144:2702-2711.
70. Shasby DM, Fox RB, Harada RN, Repine JE. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J Appl Physiol 1982; 52:1237
71. Raj U, Hazinski TA, Bland RD. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol 1985; 58:921-927.
72. Wegner CD, Wolyniec WW, LaPlante AM, et al. Intracellular adhesion molecule- 1 contributes to pulmonary oxygen toxicity in mice: role of leukocytes revisited. Lung 1992; 170:267-279.
73. Walther FJ, Kuipers IM, Pavlova Z, Willebrand D, Abuchowski A, Viau AT. Mitigation of pulmonary oxygen toxicity in premature lambs with intravenous antioxidants. Exp Lung Res 1990; 16:177-189.
74. Patterson CE, Butler JA, Byrne FD, Rhodes ML. Oxidant lung injury: intervention with sulfhydryl reagents. Lung 1985; 1985; 163:23-32.
75. Richards IM, Griffin RL, Fidler SF, Jacobsen EJ. Effect of the 21-aminoste- roid, U-74389F, on hyperoxic lung injury in rats. Agents Actions 1993; 39:C136-C138.
76. Larsson A, Orrenius S, Holmgren A, Mannervik B, eds. Functions of Glutathione: Biochemical, Physiological, Toxicological, and Clinical Aspects. New York: Raven Press, 1983.
77. Dolphin D, Avramovic O, Poulson R, eds. Glutathione: Chemical, Biochemical, and Medical Aspects. III. New York: John Wiley & Sons, 1989.
78. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharm Ther 1991; 51:155-194.
79. Reed DJ. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 1990; 30:603-631.
80. Jenkinson SG, Black RD, Lawrence RA. Glutathione concentrations in rat lung bronchoalveolar lavage fluid: effects of hyperoxia. J Lab Clin Med 1988; 112:345-351.
81. Kennedy KA, Lane NL. Effect of in vivo hyperoxia on the glutathione system in neonatal rat lung. Exp Lung Res 1994; 20:73-83.
82. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100:1397-1403.
83. Smith CV, Mitchell JR. Pharmacological aspects of glutathione in drug metabolism. In: Dolphin D, Poulson R, Avramovic O, eds. Coenzymes and Cofactors. New York: John Wiley & Sons, 1989:1-44.
84. Smith CV, Hughes H, Lauterburg BH, Mitchell JR. Chemical nature of reactive metabolites determines their biological interactions with glutathione. In: Larsson A, Orrenius S, Holmgren A, Mannervik B, eds. Functions of Glutathione: Biochemical, Physiological, Toxicological, and Clinical Aspects. New York: Raven Press, 1983:125-138.
85. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliott SJ. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 1993; 34: 360-365.
86. Rollins D, Larsson A, Steen B, et al. Glutathione and gamma-glutamyl cycle enzymes in human fetal liver. J Pharmacol Exp Ther 1981; 217:697-700.
87. Zlotkin SH, Anderson GH. Sulfur balances in intravenously fed infants: effects of cysteine supplementation. Am J Clin Nutr 1982; 36:862-867.
88. Zlotkin SH, Anderson GH. The development of cystathionase activity during the first year of life. Pediatr Res 1982; 16:65-68.
89. Corcoran GB, Racz WJ, Smith CV, Mitchell JR. Effects of -acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther 1985; 232:864-872.
90. Corcoran GB, Todd EL, Racz WJ, Hughes H, Smith CV, Mitchell JR. Effects of acetylcysteine on the disposition and metabolism of acetaminophen in mice. J Pharmacol Exp Ther 1985; 232:857-863.
91. Smith LJ, Horcher P, Anderson J, Shamsuddin M. Effect of fasting on the lung glutathione redox cycle in air- and oxygen-exposed mice: beneficial effects of sugar. J Lab Clin Med 1990; 116:717-723.
92. Huang C-S, Chang L-S, Anderson ME, Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney y-glutamylcysteine synthetase. J Biol Chem 1993; 268:19675-19680.
93. Helbling G, Von Overbeck J, Lauterburg BH. Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest 1996; 26: 38-44.
94. Buhl R, Holroyd KJ, Mastrangeli A, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 2:1294-1298.
95. Smith CV, Rogers LK, Rabin RL, Maldonado YA, Herzenberg LA, Petru A. Effects of human immunodeficiency virus (HIV) infection on plasma glutathione status in children [abstr]. Pediatr Res 1994; 35:392A.
96. Lauterburg BH, Adams JD, Mitchell JR. Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology 1984; 4:586-590.
97. Ookhtens M, Mittur AV. Developmental changes in plasma thiol-disulfide turnover in rats: a multicompartmental approach. Am J Physiol 1994; 36:R415-R425.
98. Bai C, Brown LAS, Jones DP. Glutathione transport by type II cells in perfused rat lung. Am J Physiol 1994; 267:L447-L455.
99. Lauterburg BH, Smith CV, Hughes H, Mitchell JR. Biliary excretion of glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Clin Invest 1984; 73:124-133.
100. Weis M, Cotgreave IC, Moore GA, Norbeck K, Moldeus P. Accessibility of hepato- cyte protein thiols to monobromobimane. Biochim Biophys Acta 1993; 1176:1319.
101. Gupta S, Rogers LK, Taylor SK, Smith CV. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol 1997; 146:317-327.
102. Gupta S, Kleiner HE, Rogers LK, Lau SS, Smith CV. Redox stress and hepatic DNA fragmentation induced by diquat in vivo are not accompanied by increased 8-hydroxydeoxyguanosine contents. Redox Rep 1997; 3:31-39.
103. Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzy- mol 1990; 63:69-172.
104. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 1995; 251:8-28.
105. Walker KW, Gilbert HF. Scanning and escape during protein-disulfide isomerase- assisted protein folding. J Biol Chem 1997; 272:8845-8848.
106. Moorthy B, Nguyen UT-L, Stewart KD, Welty SE, Smith CV. Induction and decline of hepatic cytochromes P4501A1 and 1A2 in rats exposed to hyperoxia are not paralleled by changes in glutathione S-transferase-a. Toxicol Lett 1997; 90: 67-75.
107. Adcock LM, Yamashita Y, Goddard-Finegold J, Smith CV. Cerebral hypoxia-isch- emia increases microsomal iron in newborn piglets. Metab Brain Dis 1996; 11: 359-367.
108. Rokutan K, Thomas JA, Sies H. Specific S-thiolation of a 30-kDa cytosolic protein from rat liver under oxidative stress. Eur J Biochem 1989; 179:233-239.
109. Seres T, Ravichandran V, Moriguchi T, Rokutan K, Thomas JA, Johnston RB Jr. Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. J Immunol 1996; 156:1973-1980.
110. Ravichandran V, Seres T, Moriguchi T, Thomas JA, Johnston RB Jr. S-Thiolation of glyceraldehyde-3-phosphate dehydrogenase by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem 1994; 269:25010-25015.
111. Lii C-K, Chai Y-C, Zhao W, Thomas JA, Hendrich S. S-Thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues. Arch Biochem Biophys 1994; 308:231-239.
112. Olafsdottir K, Reed DJ. Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. Biochim Biophys Acta 1988; 964:377-382.
113. Evers R, Zaman GJR, van Deemeter L, et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 1996; 97:1211-1218.
114. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RG. Characterization of the Mr 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 1995; 55:102-110.
115. Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S, Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. J Biol Chem 1994; 269:16638-16642.
116. Constantini P, Chernyak BV, Petronilli V, Bernardi P. Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane. FEBS Lett 1995; 362:239-242.
117. Constantini P, Chernyak BV, Petronilli V, Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxiation at two separate sites. J Biol Chem 1996; 271:6746-6751.
118. Smith LJ, Anderson J. Oxygen-induced lung damage. Relationship to lung mitochondrial glutathione levels. Am Rev Respir Dis 1992; 146:1452-1457.
119. Gyurasics A, Kelley DK, Rogers LK, Welty SE, Hansen TN, Smith CV. Mitochondrial compartmentalization of hyperoxic stresses investigated by measurement of coenzyme A (CoASH) and CoASSG in rat lungs [abstr]. Pediatr Res 1994; 35: 392A.
120. Guyton KZ, Xu Q, Holbrook NJ. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem J 1996; 314:547-554.
121. Beinert H, Kiley P. Redox control of gene expression involving iron-sulfur proteins. Change of oxidation-state or assembly/disassembly of Fe-S clusters? FEBS Lett 1996; 382:218-219.
122. Sellers VM, Johnson MK, Dailey HA. Function of the [2Fe-2S] cluster in mammalian ferrochelatase: a possible role as a nitric oxide sensor. Biochemistry 1996; 35: 2699-2704.
123. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical- mediated protein oxidation. Biochem J 1997; 324:1-18.
124. Pacifici RE, Davies KJA. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 1991; 37:166-180.
125. Grant AJ, Jessup W, Dean RT. Inefficient degradation of oxidized regions of protein molecules. Free Radic Res Commun 1993; 18:259-267.
126. De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol 1966; 28: 435-492.
127. Smith CV. Correlations and apparent contradictions in assessment of oxidant stress status in vivo. Free Radic Biol Med 1991; 10:217-224.
128. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9:515-540.
129. Kosugi H, Kikugawa K. Potential thiobarbituric acid-reactive substances in peroxi- dized lipids. Free Radic Biol Med 1989; 7:205-207.
130. Kojima T, Kikugawa K, Kosugi H. Is the thiobarbituric acid-reactivity of blood plasma specific to lipid peroxidation? Chem Pharm Bull 1990; 38:3414-3418.
131. Kikugawa K, Kojima T, Yamaki S, Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem 1992; 202:249-255.
132. Hughes H, Smith CV, Mitchell JR. Quantitation of lipid peroxidation products by gas chromatography-mass spectrometry. Anal Biochem 1986; 152:107-112.
133. Hughes H, Smith CV, Horning EC, Mitchell JR. HPLC and GC-MS determination of specific lipid peroxidation products in vivo. Anal Biochem 1983; 130:431-436.
134. Smith CV, Reilly MH. Formation of pentane versus 1-pentanol in the ferrous sulfate initiated decomposition of 15-hydroperoxyeicosatetraenoic acid in hypoxic and hyperoxic conditions. Biochem Pharmacol 1989; 38:1362-1364.
135. Morrow JD, Roberts LJI. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996; 51:1-9.
136. Longmire AW, Swift LL, Roberts LJI, Awad JA, Burk RF, Morrow JD. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Pharmacol 1994; 47:1173-1177.
137. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalyanaraman B, Freeman BA. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 1995; 324:1525.
138. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 1986; 83:4908-4912.
139. Andreoli SP. Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediatr Res 1989; 25:97-101.
140. Randerath K, Randerath E, Smith CV, Chang J. Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem Res Toxicol 1996; 9:247-254.
141. Ryan TP, Aust SD. The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol 1992; 22:119-141.
142. Balla G, Vercellotti GM, Eaton JW, Jacob HS. Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med 1990; 116:546-554.
143. Smith CV. Evidence for the participation of lipid peroxidation and iron in diquat- induced hepatic necrosis in vivo. Mol Pharmacol 1987; 32:417-422.
144. Gupta S, Rogers LK, Smith CV. Biliary excretion of lysosomal enzymes, iron, and oxidized protein in Fischer-344 and Sprague-Dawley rats and the effects of diquat and acetaminophen. Toxicol Appl Pharmacol 1994; 125:42-50.
145. Lentjes EGWM, Lindeman JHN, van de Bent W, Berger HM. Measured versus calculated latent iron binding capacity in plasma of newborns. Ann Clin Biochem 1995; 32:478-481.
146. Revenis ME, Kaliner MA. Lactoferrin and lysozyme deficiency in airway secretions: association with the development of bronchopulmonary dysplasia. J Pediatr 1992; 121:262-270.
147. deLemos RA, Roberts RJ, Coalson JJ, deLemos JA, Null DM, Gerstmann DR. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am J Dis Child 1990; 144:915-919.